Nomogram predicting the efficacy of transurethral surgery in benign prostatic hyperplasia patients.
Benign prostatic hyperplasia
Nomogram
Prediction model
Transurethral surgery
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
14 Mar 2024
14 Mar 2024
Historique:
received:
18
08
2023
accepted:
22
01
2024
medline:
18
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
epublish
Résumé
This study aimed to develop and validate a nomogram for predicting the efficacy of transurethral surgery in benign prostatic hyperplasia (BPH) patients. Patients with BPH who underwent transurethral surgery in the West China Hospital and West China Shang Jin Hospital were enrolled. Patients were retrospectively involved as the training group and were prospectively recruited as the validation group for the nomogram. Logistic regression analysis was utilized to generate nomogram for predicting the efficacy of transurethral surgery. The discrimination of the nomogram was assessed using the area under the receiver operating characteristic curve (AUC) and calibration plots were applied to evaluate the calibration of the nomogram. A total of 426 patients with BPH who underwent transurethral surgery were included in the study, and they were further divided into a training group (n = 245) and a validation group (n = 181). Age (OR 1.07, 95% CI 1.02-1.15, P < 0.01), the compliance of the bladder (OR 2.37, 95% CI 1.20-4.67, P < 0.01), the function of the detrusor (OR 5.92, 95% CI 2.10-16.6, P < 0.01), and the bladder outlet obstruction (OR 2.21, 95% CI 1.07-4.54, P < 0.01) were incorporated in the nomogram. The AUC of the nomogram was 0.825 in the training group, and 0.785 in the validation group, respectively. The nomogram we developed included age, the compliance of the bladder, the function of the detrusor, and the severity of bladder outlet obstruction. The discrimination and calibration of the nomogram were confirmed by internal and external validation.
Identifiants
pubmed: 38485798
doi: 10.1007/s40520-024-02708-8
pii: 10.1007/s40520-024-02708-8
pmc: PMC10940401
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
71Subventions
Organisme : National Key Research and Development Program of China
ID : 2021YFC2009304
Organisme : Project of Science and Technology Department of Chengdu
ID : 2021-YF05-00717-SN
Organisme : Project of Science and Technology Department of Sichuan Province
ID : 2021YFS0117
Informations de copyright
© 2024. The Author(s).
Références
Int Neurourol J. 2017 Mar 24;21(1):46-52
pubmed: 28361512
Eur Urol Focus. 2022 Sep;8(5):1331-1339
pubmed: 34922898
Clin Cancer Res. 2017 Nov 15;23(22):6904-6911
pubmed: 28874414
ACS Appl Mater Interfaces. 2022 Aug 24;14(33):37301-37315
pubmed: 35948054
PLoS One. 2021 May 24;16(5):e0251721
pubmed: 34029333
BJU Int. 2021 Apr;127(4):389-399
pubmed: 32893964
Dtsch Arztebl Int. 2020 Dec 4;117(49):843-854
pubmed: 33593479
Neurourol Urodyn. 2021 Mar;40(3):868-875
pubmed: 33645847
Low Urin Tract Symptoms. 2022 May;14(3):193-198
pubmed: 35092360
J Urol. 2018 Jan;199(1):237-244
pubmed: 28760632
Neurourol Urodyn. 2020 Apr;39(4):1115-1123
pubmed: 32110842
BJU Int. 2010 May;105(10):1429-33
pubmed: 19863522
Neurourol Urodyn. 2023 Nov;42(8):1628-1638
pubmed: 37614044
Neurourol Urodyn. 2018 Aug;37(S6):S50-S60
pubmed: 30614058
Eur Urol. 1993;24(1):12-9
pubmed: 7689968
Prostate Int. 2019 Mar;7(1):30-34
pubmed: 30937296
Neurourol Urodyn. 2017 Jun;36(5):1243-1260
pubmed: 27917521
Am J Obstet Gynecol. 2002 Jul;187(1):116-26
pubmed: 12114899
Lancet Digit Health. 2021 Jul;3(7):e445-e454
pubmed: 34167765
BJU Int. 2019 May;123(5A):E34-E42
pubmed: 30582661
J Urol. 2020 Apr;203(4):779-785
pubmed: 31647388
Minerva Urol Nefrol. 2018 Apr;70(2):211-217
pubmed: 29161806
Acta Biomater. 2022 May;144:221-229
pubmed: 35301146
Urology. 2015 Nov;86(5):1032-6
pubmed: 26284594
Eur Urol. 2014 Feb;65(2):389-98
pubmed: 24184024
Urol Int. 2014;93(4):425-30
pubmed: 25300422
Eur Urol. 2020 Feb;77(2):180-188
pubmed: 31606332
Low Urin Tract Symptoms. 2020 Jan;12(1):41-46
pubmed: 31430060
Int Urol Nephrol. 2021 May;53(5):835-841
pubmed: 33386583
Eur Urol Focus. 2019 May;5(3):340-350
pubmed: 31047905